Literature DB >> 18595643

[Which factors are predictive for long-term complaints after mild traumatic brain injuries?].

M Schütze1, G Kundt, K Buchholz, J Piek.   

Abstract

Each year 330 of every 100,000 inhabitants in Germany suffer a mild traumatic brain injury. About 25% suffer persisting post-concussion syndrome (headache, dizziness). Although many studies have been carried out to make a prognosis of the long-term outcome of these patients, there are still no relevant tests for a valuable statement. The aim of our study was to identify parameters to predict post-traumatic complaints. Therefore we conducted a prospective study of 74 patients who were admitted with a mild traumatic brain injury in our hospital from March 2004 till October 2006. We were able to show a significant correlation between complaints and a pathological CT-scan and biochemical markers during the first two weeks. For long-term complaints only the SKT (Syndromkurztest) we used for a neuropsychological assesment was able to show a significant correlation.

Entities:  

Mesh:

Year:  2008        PMID: 18595643

Source DB:  PubMed          Journal:  Versicherungsmedizin


  3 in total

Review 1.  The young brain and concussion: imaging as a biomarker for diagnosis and prognosis.

Authors:  Esteban Toledo; Alyssa Lebel; Lino Becerra; Anna Minster; Clas Linnman; Nasim Maleki; David W Dodick; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2012-03-28       Impact factor: 8.989

Review 2.  Toward a High-Resolution Neuroimaging Biomarker for Mild Traumatic Brain Injury: From Bench to Bedside.

Authors:  Manoj Kumar Jaiswal
Journal:  Front Neurol       Date:  2015-07-06       Impact factor: 4.003

Review 3.  Characteristics of patients included and enrolled in studies on the prognostic value of serum biomarkers for prediction of postconcussion symptoms following a mild traumatic brain injury: a systematic review.

Authors:  Eric Mercier; Pier-Alexandre Tardif; Marcel Emond; Marie-Christine Ouellet; Élaine de Guise; Biswadev Mitra; Peter Cameron; Natalie Le Sage
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.